AITRICS Selected as Strategic Enterprise by Hong Kong's OASES
Korean medical AI company AITRICS has joined the seventh cohort of Hong Kong's strategic enterprise program, the first Korean healthcare firm to be picked.
SUMO· the number puzzle
Dialo· learn languages by speaking
ediviewer· read EDI files like documents
giftdetect· the right gift in minutesKorean medical AI company AITRICS has been named a strategic enterprise partner in the seventh cohort of Hong Kong's Office for Attracting Strategic Enterprises (OASES), the company announced on the 6th. According to AITRICS, it is the first Korean healthcare company to be selected.
OASES is a government body set up to draw promising overseas companies to Hong Kong. Selected firms receive support covering office space and land, tax and financing, as well as staff visas and children's education. The seventh cohort adds 18 companies, including U.S. blockchain firm Solana and Swiss precious-metals refiner Valcambi SA.
Building on an existing Hong Kong footprint
AITRICS already has a base in the city. Last year, Hong Kong's Medical Device Division (MDD) approved its AITRICS-VC (VitalCare) solution, which predicts deterioration in hospitalized patients. VitalCare analyzes vital signs such as blood pressure and pulse, along with test results, to flag a sudden decline in a patient's condition early.
The company set up a Hong Kong subsidiary in May. It is now working with the University of Hong Kong's medical AI research center (CHART) and Hong Kong Gleneagles Hospital on local clinical validation and hospital adoption.
Next: public hospitals, GBA and Southeast Asia
AITRICS expects government-level backing to help extend adoption, which is currently centered on private hospitals, to public medical institutions. Using the clinical evidence and operating model built in Hong Kong, it plans to expand into the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) and Southeast Asia. The Hong Kong entity is to grow into its Asia-Pacific headquarters, and the company will hire local R&D staff.
CEO Kim Kwang-joon said it was meaningful that results built in Korean hospitals had earned the trust of a foreign government. He said the company aims to secure VitalCare's clinical evidence in Hong Kong quickly and use it to improve patient safety in the GBA and Southeast Asian healthcare settings.
Apps worth a look
SUMO: the number puzzleTap the right tiles, add them up, hit the target. Easy to learn, hard to master. Free, for all ages.
Dialo: learn languages by speakingTalk to an AI conversation partner; every sentence comes back corrected and explained in your language. 9 languages, A1 to C2.
ediviewer: read EDI files like documentsOpen EDIFACT and X12 messages, see every segment explained, convert to JSON/XML, export PDF and Excel. Runs locally, no upload.
giftdetect: the right gift in minutesPick who it is for, the occasion and their personality. The search engine reads product descriptions from local shops and ranks what fits. Free, no sign-up.
More from this day
See all →
Apple Charges $49.99 for Intelligence Usage Packs in Logic Pro
Redalpine closes $250M RAC VIII fund for European startups
Valkyrie Dynamics Raises €1M for Drone Interceptor Radar
